STOCK TITAN

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

MariMed (CSE: MRMD; OTCQX: MRMD) will report its fourth quarter and full year 2025 financial results on March 11, 2026 after market close. Management will host a conference call on March 12, 2026 at 8:00 a.m. EDT with a live webcast and playback available via MariMed investor relations.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its fourth quarter and full year 2025 financial results on March 11, 2026 after the markets close. Management will host a conference call on March 12, 2026 at 8:00 a.m. EDT to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q425 Earnings Webcast. A playback of the call will also be made available on MariMed’s Investor Relations website.

About MariMed
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, InHouse™, Nature’s Heritage™, and Vibations™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.

Company Contact:
Howard Schacter
Chief Communications Officer 
Email: hschacter@marimedinc.com
Phone: (781) 277-0007


FAQ

When will MariMed (MRMD) report fourth quarter and full year 2025 results?

MariMed will report Q4 and full year 2025 results on March 11, 2026 after markets close. According to MariMed, detailed financials and accompanying disclosures will be released then, followed by management commentary during the scheduled conference call the next morning.

What time is the MariMed (MRMD) earnings call and how can investors join the webcast?

The earnings call is scheduled for March 12, 2026 at 8:00 a.m. EDT. According to MariMed, investors can join a live webcast and later access a playback via the company’s Investor Relations website for on‑demand review.

Will MariMed (MRMD) provide a replay of the March 12, 2026 earnings call?

Yes, a replay will be available on the company’s Investor Relations site. According to MariMed, a playback of the conference call will be posted after the live event so investors can listen at their convenience.

Which stock exchanges list MariMed and what tickers should investors use for MRMD updates?

MariMed is listed on the CSE and OTCQX under the ticker MRMD. According to MariMed, investors tracking the announcement should monitor CSE: MRMD and OTCQX: MRMD for press releases, filings, and webcast links.

What should investors expect immediately after MariMed (MRMD) releases its March 11, 2026 results?

Expect a press release with results followed by a management call for commentary on March 12. According to MariMed, the company will issue financial results after market close and discuss them on the March 12 conference call and webcast.
Marimed

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Latest SEC Filings

MRMD Stock Data

56.49M
280.32M
14.7%
0.24%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Norwood